S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
Novo Nordisk Arms Wegovy to Be a Triple Threat
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
When Will the Next Bull Market Be?
NASDAQ:TCBP

TC Biopharm (TCBP) Stock Price, News & Analysis

$1.31
-0.30 (-18.63%)
(As of 04/15/2024 ET)
Today's Range
$1.30
$1.54
50-Day Range
$0.94
$1.95
52-Week Range
$0.85
$38.00
Volume
367,323 shs
Average Volume
4.11 million shs
Market Capitalization
$890,800.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1,400.00

TC Biopharm MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
106,770.2% Upside
$1,400.00 Price Target
Short Interest
Healthy
30.07% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of TC Biopharm in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.02 out of 5 stars

TCBP stock logo

About TC Biopharm Stock (NASDAQ:TCBP)

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

TCBP Stock Price History

TCBP Stock News Headlines

Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Why Is TC Biopharm (TCBP) Stock Up 78% Today?
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
TCBP Adjourns General Meeting Until a Later Date
TCBP Announces Exercise of Series D Warrants For Cash
/C O R R E C T I O N -- TC BioPharm/
VUZI, TCBP and MANU among pre-market losers
See More Headlines
Receive TCBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/15/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:TCBP
Fax
N/A
Employees
60
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1,400.00
High Stock Price Target
$1,400.00
Low Stock Price Target
$1,400.00
Potential Upside/Downside
+88,541.3%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.76 million
Book Value
$4.94 per share

Miscellaneous

Free Float
677,000
Market Cap
$1.07 million
Optionable
Not Optionable
Beta
0.32
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Bryan L. Kobel (Age 45)
    CEO & Director
  • Mr. Martin E. Thorp (Age 72)
    CFO & Director
  • Mr. Christopher Camarra
    Executive Vice President of Communications
  • Dr. Lauren Bor Ph.D.
    Head of Commercial Development Division

TCBP Stock Analysis - Frequently Asked Questions

What is TC Biopharm's stock price target for 2024?

0 brokerages have issued 1-year price objectives for TC Biopharm's shares. Their TCBP share price targets range from $1,400.00 to $1,400.00. On average, they expect the company's stock price to reach $1,400.00 in the next year. This suggests a possible upside of 106,770.2% from the stock's current price.
View analysts price targets for TCBP
or view top-rated stocks among Wall Street analysts.

How have TCBP shares performed in 2024?

TC Biopharm's stock was trading at $3.17 on January 1st, 2024. Since then, TCBP stock has decreased by 58.7% and is now trading at $1.31.
View the best growth stocks for 2024 here
.

Are investors shorting TC Biopharm?

TC Biopharm saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 204,500 shares, a drop of 68.0% from the March 15th total of 638,700 shares. Based on an average trading volume of 4,520,000 shares, the short-interest ratio is currently 0.0 days.
View TC Biopharm's Short Interest
.

When is TC Biopharm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our TCBP earnings forecast
.

When did TC Biopharm's stock split?

TC Biopharm shares reverse split on Friday, December 15th 2023. The 1-20 reverse split was announced on Friday, December 15th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did TC Biopharm IPO?

TC Biopharm (TCBP) raised $17 million in an initial public offering (IPO) on Friday, February 11th 2022. The company issued 4,100,000 shares at a price of $4.25 per share. EF Hutton acted as the underwriter for the IPO.

How do I buy shares of TC Biopharm?

Shares of TCBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TCBP) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners